TOWA PHARMACEUTICAL CO.,LTD. Logo

TOWA PHARMACEUTICAL CO.,LTD.

Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.

4553 | T

Overview

Corporate Details

ISIN(s):
JP3623150004
LEI:
Country:
Japan
Address:
門真市新橋町2番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and accessible medications. Its product portfolio encompasses a wide range of therapeutic areas, including drugs for the nervous system, digestive system, and allergic diseases, in addition to vitamins and antibiotics. The company focuses on formulation development to enhance its product offerings and contributes to healthcare by making essential medicines more widely available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 01:01
Registration Form
確認書
Japanese 8.1 KB
2025-11-11 01:00
Interim Report
半期報告書-第70期(2025/04/01-2026/03/31)
Japanese 206.2 KB
2025-06-27 08:01
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2025-06-24 05:01
Governance Information
内部統制報告書-第69期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-24 05:00
Annual Report
有価証券報告書-第69期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-06-24 05:00
Registration Form
確認書
Japanese 8.1 KB
2024-11-13 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-13 01:00
Interim Report
半期報告書-第69期(2024/04/01-2025/03/31)
Japanese 207.6 KB
2024-07-10 09:04
Registration Form
確認書
Japanese 8.1 KB
2024-07-10 09:00
Annual Report
訂正有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 849.4 KB
2024-06-27 05:54
Post-Annual General Meeting Information
臨時報告書
Japanese 24.9 KB
2024-06-26 02:02
Governance Information
内部統制報告書-第68期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-26 02:01
Registration Form
確認書
Japanese 8.1 KB
2024-06-26 02:01
Annual Report
有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 1.4 MB
2024-02-14 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all TOWA PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TOWA PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TOWA PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CITIUS ONCOLOGY, INC. Logo
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America CTOR
Citius Pharmaceuticals, Inc. Logo
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
United States of America CTXR
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
Clearmind Medicine Inc. Logo
Develops psychedelic-derived medicines for Alcohol Use Disorder and mental health conditions.
United States of America CMND
Clearside Biomedical, Inc. Logo
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
United States of America CLSD
Clene Inc. Logo
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
United States of America CLNN
Climb Bio, Inc. Logo
Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.
United States of America CLYM
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
Cocrystal Pharma, Inc. Logo
Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.
United States of America COCP

Talk to a Data Expert

Have a question? We'll get back to you promptly.